Mounjaro ^*

Mounjaro begins working after the first dose to help control blood sugar levels. However, it may take several weeks or even months to see the full effects on your blood sugar (HbA1c) and weight. The dose is typically started low and increased gradually, so the full therapeutic effect is reached over time. Consistency is key for achieving the best results.

While Mounjaro often causes significant weight loss, it is officially approved for treating type 2 diabetes. Its sister drug, Zepbound, contains the same active ingredient (tirzepatide) and is approved for chronic weight management. A doctor may prescribe Mounjaro off-label for weight loss in certain individuals who are overweight or obese and have related health issues. This decision is at the discretion of your healthcare provider.

You can inject Mounjaro at any time of day, with or without meals. The most important thing is to be consistent and administer your dose on the same day each week. Choose a time that is most convenient for you and that you are likely to remember, whether it's in the morning, afternoon, or evening. This helps maintain a stable level of the medication in your body.

If you miss a dose of Mounjaro, you should administer it as soon as you remember, as long as it is within 4 days (96 hours) of the missed dose. If more than 4 days have passed, skip the missed dose entirely and take your next dose on your regularly scheduled day. Do not take two doses within 3 days of each other.

Your Mounjaro pen should be stored in the refrigerator, between 36°F to 46°F (2°C to 8°C). Do not freeze the pen. If necessary, the pen can be kept at room temperature, up to 86°F (30°C), for no more than 21 days. Be sure to keep it in its original carton to protect it from light. Discard any pen that has been frozen or left unrefrigerated for over 21 days.

Yes, Mounjaro can be prescribed along with insulin. However, using these two medications together can increase your risk of developing low blood sugar (hypoglycemia). Your doctor will likely adjust the dose of your insulin when you start Mounjaro to reduce this risk. It's important to monitor your blood sugar levels closely and discuss any symptoms of hypoglycemia with your healthcare provider.

Many of the common side effects, such as nausea, diarrhea, and vomiting, are most common when starting Mounjaro or increasing the dose. For most people, these side effects tend to decrease or resolve completely over time as their body adjusts to the medication. If side effects persist or become bothersome, it is important to speak with your healthcare provider.

No, Mounjaro and Ozempic are not the same, though they work in similar ways. Ozempic is a GLP-1 receptor agonist, while Mounjaro is a dual GLP-1 and GIP receptor agonist. This means Mounjaro targets two different pathways to control blood sugar and appetite. Studies have shown that Mounjaro may lead to greater reductions in blood sugar and weight compared to GLP-1 agonists alone.

When used on its own, Mounjaro is unlikely to cause low blood sugar (hypoglycemia) because its action is glucose-dependent, meaning it works when your blood sugar is high. However, the risk increases significantly if you take it with other medications that lower blood sugar, such as insulin or sulfonylureas. Your doctor may need to adjust your other medications to minimize this risk.

You should inject Mounjaro under the skin (subcutaneously) in your abdomen, thigh, or upper arm. It is important to rotate your injection site with each weekly dose. For example, if you used your thigh one week, use your abdomen or upper arm the next week. Avoid injecting into the exact same spot to prevent skin irritation, lumps, or scarring.

You should talk to your doctor about alcohol consumption. Alcohol can affect your blood sugar levels, causing them to go too high or too low, which can be risky when taking diabetes medication like Mounjaro. It can also increase the risk of pancreatitis. Your doctor can give you personalized advice based on your health status and treatment plan.

In people with existing kidney problems, side effects like diarrhea, nausea, and vomiting can lead to dehydration, which may worsen kidney function. It is very important to stay well-hydrated by drinking plenty of fluids to reduce this risk. If you have a history of kidney disease, your doctor will monitor your condition while you are taking Mounjaro.

In studies with rats, Mounjaro's active ingredient, tirzepatide, caused an increase in thyroid C-cell tumors. It is not known if this also happens in humans. Due to this potential risk, the FDA requires a boxed warning. You should not use Mounjaro if you or a family member has ever had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).